Genedart Biotechnology Co., Ltd. – Trademark Portfolio
Entity Type: 03
Genedart Biotechnology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include GENEDARTEC.
Room 4-4-1248, 1st-2nd Floors, Building 8,
No. 9 Courtyard, Yuxi Road, Houshayu Town, Shunyi District Beijing
Showing of trademarks Trademarks
Trademark Classifications
Genedart Biotechnology Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Genedart Biotechnology Co., Ltd. have?
Genedart Biotechnology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.
What trademark classes does Genedart Biotechnology Co., Ltd. file in?
Genedart Biotechnology Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 30 (Staple Foods). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Genedart Biotechnology Co., Ltd.'s most well-known trademarks?
Genedart Biotechnology Co., Ltd.'s registered trademark portfolio includes well-known marks such as GENEDARTEC. These are among 1 currently registered trademark in the portfolio.
What is Genedart Biotechnology Co., Ltd.'s trademark registration success rate?
Genedart Biotechnology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.